David Drew to Humans
This is a "connection" page, showing publications David Drew has written about Humans.
Connection Strength
0.067
-
Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020 06 19; 368(6497):1362-1367.
Score: 0.007
-
Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression. Mol Cancer Res. 2018 03; 16(3):486-495.
Score: 0.006
-
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Trials. 2017 02 01; 18(1):50.
Score: 0.006
-
Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients. Am J Kidney Dis. 2017 Jun; 69(6):780-787.
Score: 0.006
-
A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers. Am J Gastroenterol. 2017 03; 112(3):493-501.
Score: 0.006
-
Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study. J Am Soc Nephrol. 2017 Jun; 28(6):1859-1866.
Score: 0.006
-
Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study. Lancet Digit Health. 2021 09; 3(9):e587-e598.
Score: 0.002
-
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Lancet Digit Health. 2021 09; 3(9):e577-e586.
Score: 0.002
-
Association of social distancing and face mask use with risk of COVID-19. Nat Commun. 2021 06 18; 12(1):3737.
Score: 0.002
-
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021 07; 21(7):939-949.
Score: 0.002
-
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health. 2021 05; 6(5):e335-e345.
Score: 0.002
-
Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app. Sci Adv. 2021 03; 7(12).
Score: 0.002
-
Attributes and predictors of long COVID. Nat Med. 2021 04; 27(4):626-631.
Score: 0.002
-
Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study. Lancet Public Health. 2021 01; 6(1):e21-e29.
Score: 0.002
-
Cancer and Risk of COVID-19 Through a General Community Survey. Oncologist. 2021 01; 26(1).
Score: 0.002
-
Building an international consortium for tracking coronavirus health status. Nat Med. 2020 08; 26(8):1161-1165.
Score: 0.002
-
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 09; 5(9):e475-e483.
Score: 0.002
-
Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020 07; 26(7):1037-1040.
Score: 0.002
-
The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action. Cancer Epidemiol Biomarkers Prev. 2020 07; 29(7):1283-1289.
Score: 0.002
-
Stability of the human faecal microbiome in a cohort of adult men. Nat Microbiol. 2018 03; 3(3):347-355.
Score: 0.002
-
Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nat Microbiol. 2018 03; 3(3):356-366.
Score: 0.002
-
Discrepancies between Perceived and Measured Cognition in Kidney Transplant Recipients: Implications for Clinical Management. Nephron. 2018; 138(1):22-28.
Score: 0.001
-
Long-term use of antibiotics and risk of colorectal adenoma. Gut. 2018 04; 67(4):672-678.
Score: 0.001
-
Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. Gastroenterology. 2017 06; 152(8):1944-1953.e1.
Score: 0.001